Impact of corporate environmental uncertainty on environmental, social, and governance performance: The role of government, investors, and geopolitical risk.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2024
Historique:
received: 28 03 2024
accepted: 13 08 2024
medline: 27 8 2024
pubmed: 27 8 2024
entrez: 27 8 2024
Statut: epublish

Résumé

Corporations face multifaceted environmental uncertainties (EU) in today's dynamic global economic environment. Such uncertainties profoundly affect corporate operations and pose significant challenges to their environmental, social, and governance (ESG) performance. Therefore, using data from Chinese A-share listed corporations from 2009 to 2021, we empirically analyze the impact of the EU on ESG performance. The results demonstrate that the EU significantly negatively impacts ESG performance, indicating that corporations frequently find it difficult to implement and maintain high-standard ESG policies and practices effectively. Additionally, they reveal that the EU inhibits the improvement of ESG performance by increasing corporate financing constraints (KZ). Lastly, this study explores the role of government subsidies (GOV), investor attention (IA), and geopolitical risks (GPR) as moderating variables. We discover that GOV can mitigate the negative impact of the EU on KZ because they provide additional resources that help corporations maintain their ESG in uncertain environments. Furthermore, IA can reduce the adverse impact of KZ on ESG. Positive moderating effects result from ESG issues; the capital they provide effectively reduces corporate KZ, thus enabling corporations to maintain good ESG performance despite operating in highly uncertain environments. However, due to the increased asymmetry of information in economic markets caused by geopolitical tensions, GPR exacerbates the negative impact of the EU on ESG performance, thus leading to an increase in KZ. These findings offer new perspectives on understanding how these moderating effects affect corporate ESG strategies.

Identifiants

pubmed: 39190725
doi: 10.1371/journal.pone.0309559
pii: PONE-D-24-12511
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0309559

Informations de copyright

Copyright: © 2024 Guo et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Auteurs

Xiao Guo (X)

Department of International Trade, Jeonbuk National University, Jeonju-si, Jeollabuk-do, Republic of Korea.

Pengfei Cheng (P)

Department of Financial Management, Hubei University of Automotive Technology, Shiyan City, Hubei Province, China.

Baekryul Choi (B)

Department of International Trade, Jeonbuk National University, Jeonju-si, Jeollabuk-do, Republic of Korea.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH